These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
109 related items for PubMed ID: 29546279
21. [Predictive and prognostic factors of preeclampsia: Interest of PlGF and sFLT-1]. Vieillefosse S, Guibourdenche J, Atallah A, Haddad B, Fournier T, Tsatsaris V, Lecarpentier E. J Gynecol Obstet Biol Reprod (Paris); 2016 Nov; 45(9):999-1008. PubMed ID: 27212611 [Abstract] [Full Text] [Related]
22. Placental-specific sFLT-1: role in pre-eclamptic pathophysiology and its translational possibilities for clinical prediction and diagnosis. Palmer KR, Tong S, Kaitu'u-Lino TJ. Mol Hum Reprod; 2017 Feb 10; 23(2):69-78. PubMed ID: 27986932 [Abstract] [Full Text] [Related]
23. Difference of concentration of placental soluble fms-like tyrosine kinase-1(sFlt-1), placental growth factor (PlGF), and sFlt-1/PlGF ratio in severe preeclampsia and normal pregnancy. Gurnadi JI, Mose J, Handono B, Satari MH, Anwar AD, Fauziah PN, Yogi Pramatirta A, Rihibiha DD. BMC Res Notes; 2015 Oct 04; 8():534. PubMed ID: 26434493 [Abstract] [Full Text] [Related]
24. HtrA3 Isoform-Specific ELISAs for Early Detection of Preeclampsia. Wang Y, Li Y, Hyett J, da Silva Costa F, Nie G. SLAS Discov; 2018 Dec 04; 23(10):1092-1099. PubMed ID: 27932697 [Abstract] [Full Text] [Related]
30. Second-trimester angiogenic factors as biomarkers for future-onset preeclampsia. Unal ER, Robinson CJ, Johnson DD, Chang EY. Am J Obstet Gynecol; 2007 Aug 04; 197(2):211.e1-4. PubMed ID: 17689655 [Abstract] [Full Text] [Related]
31. Differential diagnosis of preeclampsia: remember the soluble fms-like tyrosine kinase 1/placental growth factor ratio. Verdonk K, Visser W, Russcher H, Danser AH, Steegers EA, van den Meiracker AH. Hypertension; 2012 Oct 04; 60(4):884-90. PubMed ID: 22892815 [No Abstract] [Full Text] [Related]
32. Soluble Fms-like tyrosine kinase-1 to placental growth factor ratio in mid-pregnancy as a predictor of preterm preeclampsia in asymptomatic pregnant women. Forest JC, Thériault S, Massé J, Bujold E, Giguère Y. Clin Chem Lab Med; 2014 Aug 04; 52(8):1169-78. PubMed ID: 24535301 [Abstract] [Full Text] [Related]
33. Dysregulation of circulating autoantibodies against VEGF-A, VEGFR-1 and PlGF in preeclampsia - A role in placental and vascular health? Moe K, Heidecke H, Dechend R, Staff AC. Pregnancy Hypertens; 2017 Oct 04; 10():83-89. PubMed ID: 29153696 [Abstract] [Full Text] [Related]
34. Redefining preeclampsia using placenta-derived biomarkers. Staff AC, Benton SJ, von Dadelszen P, Roberts JM, Taylor RN, Powers RW, Charnock-Jones DS, Redman CW. Hypertension; 2013 May 04; 61(5):932-42. PubMed ID: 23460278 [No Abstract] [Full Text] [Related]
40. Evidence supporting that the excess of the sVEGFR-1 concentration in maternal plasma in preeclampsia has a uterine origin. Bujold E, Romero R, Chaiworapongsa T, Kim YM, Kim GJ, Kim MR, Espinoza J, Gonçalves LF, Edwin S, Mazor M. J Matern Fetal Neonatal Med; 2005 Jul 04; 18(1):9-16. PubMed ID: 16105786 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]